Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms

Patients will receive intradermal injection of individualized neoantigen peptides vaccine at a dose of \~500ug per peptide once a week for 4 weeks, and every month for 5 months after that.